Pharma giant MSD is to invest €11.5m in its Carlow site
In a recent announcement MSD has unveiled a €11.5 million investment at its vaccines plant in Carlow.
It is the latest phase of a €312 million seven-year investment at the site, which is MSD’s first standalone human vaccines operation worldwide.
The pharma company, which employs more than 2,000 people across its sites in Dublin, Carlow, Cork, Tipperary and Wicklow, made the announcement during a visit by the U S ambassador to Ireland, Kevin O’Malley.
The company also said the investment shows it ongoing commitment to Carlow and the local community which currently has a workforce of about 450 people.
The state-of-the-art 200,000sq ft biologics operation produces vaccines for customers across the world. It is also leading MSD’s work in the development of a new oncology treatment.
MSD, which is known as Merck in the US and Canada, has operations in over 140 countries.
“The production facilities here in Carlow are best in class internationally and this substantial investment reflects MSD’s ongoing commitment, both to Carlow and to supporting the growth and expansion of innovative product lines led by a highly-skilled Irish workforce”
Jean-Albert Pittaluga, Executive Director MSD